CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway

Blood

Volumn 96, Issue 1, 2000, Pages 195-202

  Tateyama, Masaki ^b   Oyaizu, Naoki ^b   McCloskey, Thomas W ^b   Than, Soe ^b   Pahwa, Savita ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; PROTEIN BCL X; T LYMPHOCYTE RECEPTOR; VIRUS RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CONTACT; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0034234670     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.195     Document Type: Article

References (45)

1. + lymphocyte homeostasis during the natural course of HIV-1 infection. J Clin Invest. 1998;101:137.
2. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science. 1992;257:217
3. + T cells from HIV-infected persons. J Immunol. 1994;153:412.
4. + T cell turnover. Science. 1996;274:1543.
5. Pantaleo G, Soudeyns H, Demarest JF, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8 T cell clones during primary HIV infection. Proc Natl Acad Sci U S A. 1997;94:9848.
6. Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med. 1999;5:34.
7. + T cells by a Fas-independent mechanism. J Exp Med. 1998;187:1113.
8. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med. 1995;181:2029
9. Dockrell DH, Badley AD, Villacian JS, et al. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest. 1998;101:2394.
10. Hosaka N, Oyaizu N, Kaplan MH, Yagita H, Pahwa S. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected person. J Infect Dis. 1998;178:1030.
11. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, et al. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med. 1997;186:1365.
12. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen Nature. 1990;347:286.
13. Banda NK, Berniern J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med. 1992;176:1099.
14. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 1993;82: 3392.
15. Wang Z, Dudhane A, Orlikowsky T, et al. CD4 engagement induce Fas antigen-dependent apoptosis in vivo. Eur J Immunol. 1994;24:1549.
16. + T cells. Proc Natl Acad Sci U S A. 1996;93: 11014.
17. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood. 1994;84:2622.
18. + T cells apoptosis. J Immunol. 1997;158:2456
19. Algeciras A, Dockrell DH, Lynch DH, Paya CV. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med. 1998;187:711.
20. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med. 1997; 185:55.
21. Cheng JT, Zhou C, Liu JP, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759.
22. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled Annexin V. J Immunol Methods. 1995;184:39.
23. McCloskey TW, Oyaizu N, Coronesi M, Pahwa S. Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes. Clin Immunol Immunopathol. 1994;71:14.
24. Oyaizu N, Than S, McCloskey T, Pahwa S. Requirement of p56lck in T cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat T cells. Biochem Biophys Res Commun. 1995; 213:994.
25. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med. 1996;2:317.
26. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387:773.
27. Dhein J, Walczak H, Baumler C. Debatin K, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 1995;373:438.
28. Ju S, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995;373:444.
29. Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med. 1995;181: 71.
30. Boise LH, Minn AJ. Noel PJ, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 1995;3:87.
31. Oyaizu N, Kayagaki N, Yagita H, Pahwa S, Ikawa Y. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells. Biochem Biophys Res Commun. 1997;238:670.
32. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med. 1998; 4:31.
33. Groux H, Monte D, Plouvier B, Capron A, Ameisen JC. CD3-medialed apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-γ and accessory Cells. Eur J Immunol. 1993;23:1623.
34. Sasiain MDC, Barrera SDL, Fink S, et al. IFN-γ and TNF-α are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by mycobacterium leprae heat shock protein 65 kD. Clin Exp Immunol. 1998;114:196.
35. Radrizzani M, Accornero P, Amidei A, et al. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol. 1995; 161:14.
36. Kovac JA, Vogel SV, Albert JM, et al Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med. 1996;335:1350.
37. Adachi Y, Oyaizu N, Than S, McCloskeyTW, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. J Immunol. 1996;157:4184.
38. Dudhane A, Conti B, Orlikowsky T, et al. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses. 1996;12:885.
39. + patients. Int Immunol. 1998;10: 1847.
40. Finkel TH, Tudor-Williams G, Banda NK, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med. 1995;1: 129.
41. + T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J Virol. 1998;72:4623.
42. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest. 1990;86:148.
43. Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science. 1994;265:248.
44. Chavan S, Tamma L, Kaplan M, Gersten M, Pahwa S. Reduction in virus load leads to decrease in lymphocyte apoptosis in HIV infected patients following antiretroviral therapy. Clin Immunol. 1999;93:24.
45. Badley AD, Dockrell DH, Algeciras A, et al. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest. 1998;102:79.